心血管遗传学中的成长之痛
本文回顾了心血管遗传学从家族连锁分析发现首批疾病基因到广泛面板测序的应用历程,指出当前 Circulation 两篇论文提示,在大规模患者人群中扩大使用这些测序面板所依据的逻辑可能存在缺陷。
要点
- 连锁分析在大家系中发现了首批心血管遗传病基因,奠定了病理生理理解与家族咨询的基础。
- 外显不全常见,首批疾病基因编码区变异阴性者仍可能通过通路候选基因解释表型。
- 测序成本与效率大幅改善使面板测序广泛应用,但两篇论文提示其底层逻辑可能存在缺陷。
核心结论
- 心血管遗传学在基因发现与测序应用上取得显著进展,但大规模面板测序的底层逻辑可能存在缺陷。
研究设计与样本
- 本文为综述性评论,回顾半个世纪以来心血管遗传学从连锁分析到面板测序的发展历程。
主要发现
- 连锁分析在大家系中识别出首批疾病基因,对理解心脏生理病理、家族咨询、定义外显不全及识别编码区变异阴性患者具有关键意义。
- 基于早期连锁研究定义的疾病通路,可提示新的候选基因,如肥厚型心肌病中β-肌球蛋白重链突变后其他收缩蛋白基因成为候选。
- 离子通道基因或修饰基因在通道病、桥粒蛋白基因在致心律失常性右室心肌病中成为候选,形成了主要心血管遗传病的较长疾病基因列表。
- 测序成本与效率的显著改善使面板测序得以广泛应用,改善了患者及家族照护。
- 本期 Circulation 两篇论文提示,在大人群中扩大使用这些面板所依据的逻辑可能存在缺陷。
临床怎么用
- 临床应认识到面板测序的广泛应用需审慎评估其逻辑基础,尤其在大规模人群筛查场景。
局限性
- 本文为评论性文章,未报告原始研究数据或系统检索范围。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Over half a century ago, heart specialists – there were no board certified cardiologists yet – began to report unusual phenotypes like very long QT intervals or extraordinary left ventricular hypertrophy that ran in families and caused sudden death in the young. In the 1980s and 90s, linkage analysis in large families identified the first disease genes, landmark discoveries that have been critical for understanding basic physiologic and pathophysiologic processes in the heart, counselling families, defining penetrance that is so often incomplete, and identifying phenotype positive patients in whom coding region variants in these first disease genes were absent. In those patients, disease pathways defined by early rigorous linkage-based studies implicated new candidate genes for mediating these cardiovascular genetic phenotypes. So, for example, once beta-myosin heavy chain mutations were identified in hypertrophic cardiomyopathy (HCM), genes encoding other contractile proteins became logical candidates; similarly, ion channel genes or modifiers were candidates in channelopathies and desmosomal proteins in arrhythmogenic right ventricular cardiomyopathy (ARVC). As a result, we now have long lists of disease genes for major cardiovascular genetic diseases, and dramatic improvements in sequencing costs and efficiencies have enabled widespread application of panel-based sequencing. While these advances have improved care of affected patients and their families, two papers in the current issue of Circulation highlight potential flaws in the logic that underlies increasing use of these panels across large patient populations.,
引用
- Roden DM. Growing Pains in Cardiovascular Genetics. Circulation. 2018. PMID: 30354441. doi:10.1161/CIRCULATIONAHA.118.035933
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。